关注
Danielle Kamato
Danielle Kamato
National Heart Foundation - Future Leader Fellow and Group Leader, Griffith University; Griffith
在 griffith.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies
S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ...
Pharmacological reviews 73 (3), 924-967, 2021
5282021
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation
D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ...
Cellular signalling 25 (10), 2017-2024, 2013
3142013
Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11
D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ...
Frontiers in Cardiovascular Medicine 2, 129046, 2015
1342015
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin
Pharmacology & therapeutics 196, 15-43, 2019
1232019
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
X Ma, Z Liu, I Ilyas, PJ Little, D Kamato, A Sahebka, Z Chen, S Luo, ...
International journal of biological sciences 17 (8), 2050, 2021
1162021
Endothelial function and dysfunction: Impact of metformin
A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ...
Pharmacology & therapeutics 192, 150-162, 2018
1152018
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics
Z Liu, X Ma, I Ilyas, X Zheng, S Luo, PJ Little, D Kamato, A Sahebkar, ...
Theranostics 11 (9), 4502, 2021
872021
Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes
M Asrafuzzaman, Y Cao, R Afroz, D Kamato, S Gray, PJ Little
Biomedicine & Pharmacotherapy 89, 1242-1251, 2017
802017
Treatment of atherosclerotic plaque: perspectives on theranostics
Y Zhang, A Koradia, D Kamato, A Popat, PJ Little, HT Ta
Journal of Pharmacy and Pharmacology 71 (7), 1029-1043, 2019
692019
Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles
KX Vazquez-Prada, J Lam, D Kamato, ZP Xu, PJ Little, HT Ta
Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 601-613, 2021
612021
Gaq proteins: molecular pharmacology and therapeutic potential
D Kamato, P Mitra, F Davis, N Osman, R Chaplin, PJ Cabot, R Afroz, ...
Cellular and Molecular Life Sciences 74, 1379-1390, 2017
602017
Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis
HT Ta, N Arndt, Y Wu, HJ Lim, S Landeen, R Zhang, D Kamato, PJ Little, ...
Nanoscale 10 (31), 15103-15115, 2018
592018
The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle
MA Rostam, D Kamato, TJ Piva, W Zheng, PJ Little, N Osman
Cellular Signalling 28 (8), 956-966, 2016
552016
Endothelial dysfunction and cardiovascular disease: History and analysis of the clinical utility of the relationship
PJ Little, CD Askew, S Xu, D Kamato
Biomedicines 9 (6), 699, 2021
482021
The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier
D Kamato, MA Rostam, R Bernard, TJ Piva, N Mantri, D Guidone, ...
Cellular and molecular life sciences 72, 799-808, 2015
452015
Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle
HB Rezaei, D Kamato, G Ansari, N Osman, PJ Little
Clinical and Experimental Pharmacology and Physiology 39 (8), 661-667, 2012
432012
Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease
Y Zhou, PJ Little, HT Ta, S Xu, D Kamato
Pharmacology & Therapeutics 204, 107404, 2019
412019
Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells
R Mohamed, P Dayati, RN Mehr, D Kamato, F Seif, ...
Journal of cell Communication and Signaling 13, 225-233, 2019
412019
Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes
D Kamato, L Thach, R Getachew, M Burch, MD Hollenberg, W Zheng, ...
Cellular signalling 28 (1), 110-119, 2016
402016
Mouse models of atherosclerosis in translational research
I Ilyas, PJ Little, Z Liu, Y Xu, D Kamato, BC Berk, J Weng, S Xu
Trends in Pharmacological Sciences 43 (11), 920-939, 2022
372022
系统目前无法执行此操作,请稍后再试。
文章 1–20